JCAR017
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for JCAR017, covering 2024-04-04 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) [Phase 1, Phase 2]